DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Clinicaltrials.gov.
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs. Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522).
Online:
https://clinicaltrialsgov/ct2/show/NCT03036488%202019 last access: 24.07.2019
We do not assume any responsibility for the contents of the web pages of other providers.